Votrient 400 mg - Pazopanib Film-Coated Tablets (30 Tablets)

Votrient (Pazopanib) 400 mg is a targeted oral therapeutic agent. A trusted solution from Novartis designed for the management of specific oncological conditions, available in a convenient 30-tablet pack.

EGP 9,280

In Stock

Delivery to governorates within 3-4 working days

Easy returns within 14 days

Specifications

SKU	CT-46
Color	Luscious Blackberry

About the product›

Votrient 400 mg: Targeted Oral Oncology Therapy

Votrient (Pazopanib) 400 mg is a kinase inhibitor indicated for the treatment of patients with advanced oncological conditions. By inhibiting specific tyrosine kinases, Votrient helps restrict the growth and spread of tumor cells, offering a potent oral treatment option.

Therapeutic Features

Targeted Inhibition: A sophisticated oral formula by Novartis that focuses on disrupting the signaling pathways required for tumor progression.
Convenient Oral Administration: Designed as film-coated tablets for ease of use, ensuring patients can maintain their therapeutic regimen effectively.
Clinical Reliability: Backed by rigorous manufacturing standards to ensure stability and consistent pharmacokinetic performance.

Important Usage Protocols & Storage

Attention: This product is a prescription-only (Rx Only) medication. It must be used strictly under the supervision of a qualified oncologist. Follow all dosage instructions provided by your healthcare professional.

Storage: Keep in a cool, dry place, away from direct sunlight and heat. Keep out of reach of children.

Disclaimer: Votrient is an Rx-only medication intended for professional healthcare use. This information is for educational purposes and is not a substitute for professional clinical judgment. Please refer to the full prescribing information provided by the manufacturer before administration.